Leticia specializes in marketing within orthopedics, cardiovascular, and neuromodulation. With over 15 years in the healthcare industry, she's made a mark by managing product portfolios and launching multiple disruptive technologies. Leticia has transformed launch practices in Fortune 500 companies and excelled in deploying AI in product development and remote monitoring.                 

Dr. Justin Barad co-founded a pioneering MedTech VR training platform, utilizing his extensive education and specialization in pediatric orthopedic trauma to revolutionize medical education. He combines advanced surgical skills with innovative tech-driven solutions, markedly improving patient outcomes and elevating professional training standards. Dr. Barad's unique integration of clinical expertise and technological innovation places him at the cutting edge of medical practice and education.

Mike Behr, with a rich 30-year background in the Life Sciences sector, specializes in steering start-ups from their initial ideation through development to successful commercialization. His adept leadership in securing intellectual property rights, establishing regulatory pathways, and devising robust reimbursement strategies has been pivotal. His proficiency in fundraising and strategic partnerships has culminated in innovation awards and significant acquisitions. Mike's governance roles across various boards highlight his dedication to fostering growth and excellence within the industry.

Rodney Brenneman, a mechanical engineer with a remarkable 30-year tenure, is a seasoned veteran and a leading force in the medical device sector. He has held influential roles ranging from CEO and Board member to advisor and consultant for numerous emerging medical technology enterprises. Rodney's vast experience cuts across multiple specialties, including vascular, general surgery, interventional cardiology, and more. Rodney excels in all facets of medical device development, from R&D to board management and physician training. He thrives in spearheading small, nimble teams dedicated to addressing clinical challenges and creating procedural advancements.

With over 30 years of experience in MedTech, Paul boasts a diverse skill set focusing on marketing, including front-end innovation, category creation, Voice of the Customer (VOC) strategy, requirements cascade, usability (HFE), and evidence generation/claims strategy. In his most recent role as an Executive in Residence (EIR) at the University of Cincinnati, Paul spearheaded all business aspects for a physician-led startup, overseeing product positioning, launch strategy, financials, and licensing agreements.

 Prior to his tenure at the University of Cincinnati, Paul held progressive leadership roles in product development, market development, and commercial execution for early-stage businesses. A significant highlight of his career includes successfully developing and launching a pioneering PMA technology, where he served as General Manager. Additionally, Paul led the seamless integration of three acquisitions into the global business, overseeing all business functions.

Paul's earlier experience encompasses sales and product management for infusion pumps and related consumables. His expertise spans technology areas such as fluid/drug delivery, patient monitoring, and respiratory care, with a deep understanding of both disposable and capital equipment.

​Ryan Childs is an accomplished Sales & Marketing executive in the MedTech Industry, with 20+ years in Medtech, his vast experience spans multiple specialties in the orthopedic market (Oncology, Pediatrics, Sports, Joints, Trauma, Robotics and Biomedical). He has worked with Fortune 500 companies, Startups and Private Equity.  Ryan has succeeded through effective communication, strategic planning, and tactical execution. He is focused on results and has an ability to thrive in fast-paced, high-growth environments.  Ryan has demonstrated an ability to develop short-term and long-term business development strategies bringing value to medical device organizations. His comprehensive background in healthcare sales and marketing has allowed him to succeed in delivering on strategic growth initiatives.  Throughout his career he has led teams to success in all areas of Medtech and he continues to shape the future for companies supporting teams to impact the future for themselves and the organization.

With over 20 years of experience in the medical device and development sector, Dan Clark has made significant contributions from his early days supporting Tier-2 suppliers to shaping the industry's future. As a detail-oriented professional with a focus on scalability, Dan co-founded a health science company, steering it through its product lifecycle and establishing it as an early-stage success. His dedication lies in aiding MedTech innovations, believing in the power of supporting remarkable teams to create impactful solutions.

Jessica Czamanski brings 13 years of experience in the medical device sector, with a focus on Regulatory Affairs, Quality Assurance, and Product Development, particularly within startup environments. In the last seven years, she has specialized in Regulatory consulting, skillfully navigating pre-submissions and market submissions across the US, Canada, EU, Australia, and Japan for diverse medical device types. Her expertise covers a broad range of medical disciplines, making her a strategic asset for regulatory strategy and compliance in the global medical device industry.

With over 25 years of experience in the MedTech, BioTech, and cardiovascular sectors, Jim Delor is a seasoned senior executive known for driving innovation and commercial success in the healthcare industry. His deep expertise spans the entire product lifecycle, from initial concept and clinical validation to global commercialization, where he consistently delivers strategic insights and marketing excellence.

Jim has a proven track record of leading global product strategies, overseeing cross-functional teams through complex development processes, and successfully launching disruptive technologies into competitive markets. His keen insight into the global healthcare landscape allows him to effectively align product development with market demands, ultimately driving patient impact and creating substantial business value.

As an advisor to startups, investors, and established firms, Jim blends strategic planning with hands-on execution to accelerate development timelines, navigate regulatory challenges, and unlock the full potential of transformative technologies. A passionate advocate for life science innovation, Jim excels at transforming obstacles into competitive advantages and turning breakthrough ideas into tangible clinical solutions.

Rick Ditto is a seasoned professional with a strong background in facility economics and payer strategy in the healthcare industry. Currently serving as the Vice President of Global Health Economics, Reimbursement & Policy, Rick is at the forefront of leading strategies to enhance reimbursement processes and improve patient access to cutting-edge peripheral nerve repair solutions.

Rick's career journey started as an engineer, where he noticed a shift in the decision-making landscape within the medtech industry, prompting him to pivot towards enhancing patient access to pioneering technologies. As the first employee at a company later acquired by GHX, Rick spent over a decade collaborating with strategic partners, honing his expertise in healthcare economics and market access strategies.

With a wealth of experience and insights gained over the years, Rick is recognized for his valuable contributions in guiding companies on developing effective go-to-market reimbursement strategies, making him an invaluable asset in navigating the complexities of the healthcare reimbursement landscape.

Jerry DeVries is a consummate professional with 30+ years of diverse experience in healthcare, specializing in the development and management of businesses across a variety of sectors. His career spans private equity, medical devices, healthcare IT, hospitals, venture capital, and industry-wide fundraising efforts. With his strategic involvement, Jerry has played a pivotal role in steering multiple companies towards successful exits.

Dr. Easley serves as the Director of a preclinical surgical research laboratory at a highly regarded medical institute. He has 12 years of experience in the development and evaluation of orthopedic and sports medicine devices, emphasizing the creation of large animal models that replicate human conditions. Dr. Easley expertise extends to FDA regulatory processes. His leadership continues to shape the future of veterinary and translational medicine.

Within the field of medtech and diagnostics, Michael Harman has driven commercial projects from inception to launch, generating over $35 million in total sales through establishing effective partnerships and managing stakeholders towards win-win business scenarios. Amongst other things, his major contributions to the field include conception and launch of a rapid point of care sepsis diagnostic, an emergency-use rapid anticoagulant identification test, and clinical adoption of a functional oncology therapeutic selection test. Michael is an experienced technology and innovation leader with a track record of identifying technologies for enabling business growth.

Addie Harris has a robust history of entrepreneurship spanning software, medtech, medical devices, and robotics industries. Currently serving as the CEO of a robotics and digital technology incubator, Addie also holds board and advisory roles with over a dozen companies in various sectors. Previously, she established herself as the founder and CEO of a robotics company which was acquired by a prominent organization in 2019. Addie's career includes key roles at well-known robotics endeavors, including serving as an R&D leader at a major corporation, where she founded the orthopedic robotics organization, acquired a robotics company, and successfully led a robotic surgical solution from development to commercial launch.

Addie's areas of expertise include entrepreneurship in software, medtech, medical devices, and robotics industries. She has a strong background in founding and leading companies in these sectors.

David Hook is a seasoned medical device executive with a focus on market development, sales leadership, and professional education. During his tenure as the Vice President of Market Development at a medical device company, David played a pivotal role in the successful scaling of a specific implant and its acquisition. His expertise in sales, engaging thought leaders, and conducting clinical studies significantly accelerated the adoption of products within the medical device industry.

Prior to his role at the aforementioned company, David held leadership positions at various organizations, where he played a role in the market development, medical education, and sales initiatives. His contributions at different companies have included facilitating significant acquisitions, introducing groundbreaking biologic technology, and directing global professional education programs, leading to notable increases in surgeon training.

David's strategic approach to commercial strategy, focus on education, and commitment to driving market growth have positioned him as a key figure in advancing medical technologies and enhancing patient care standards.

Kristin Johnson is an experienced entrepreneur and advisor with nearly 30 years in medical device innovation, specializing in operations, R&D, and strategy. She co-founded a surgical company, serving as CEO for eight years. Previously, she contributed significantly to multiple medical device companies, impacting major product platforms and technological advancements. Holding 79 medical device patents, Kristin is known for her innovative approach. Kristin is a testament to the transformative power of vision combined with technical expertise, making her asset focused on the pursuit of medical device innovation.

Rajit Kamal is a seasoned leader in medical technology, currently spearheading robotic surgical initiatives as Vice President and General Manager at a leading firm. With a robust background in global product management and commercialization, he has previously enhanced a major segment of a healthcare conglomerate's orthopedic business, notably in sports medicine.

His career trajectory includes pivotal roles in Asia Pacific markets and a track record of success at well-known consulting firms, advising on healthcare strategies and innovation. Rajit's educational foundation is strong with advanced degrees in Chemical Engineering and Technology Management, as well as an MBA from a prestigious institution. His well-rounded expertise in leadership, strategic vision, and market growth speaks to his significant contributions to the medical device industry.

Thomas Ruggia stands as a strategic force in the world of ophthalmology with 25 years of experience. His nuanced grasp of global healthcare markets and prowess in navigating product lifecycle from development to market entry have consistently delivered value. His tenure includes influential roles in leading healthcare companies, steering commercial strategies and enhancing customer experiences across global markets. Ruggia's academic background in science underpins his strategic insights, making him a valuable asset to any team aiming for groundbreaking achievements in healthcare.

Edward Sawyer is a seasoned Chief Financial Officer with over 25 years of hands-on leadership in the healthcare industry. His expertise spans pharmaceuticals, medical devices, and diagnostics, emphasizing high-impact financial management and team development. With a solid executive background, he has a proven track record of scaling infrastructure and navigating complex strategic challenges in rapidly growing companies. His involvement in the healthcare sector showcases his commitment to advancing the industry through strategic initiatives and operational excellence.

Kenny Simmen, PhD, is a recognized biopharma scientific and business advisor with 30 years of global pharmaceutical expertise. With significant experience at prominent pharmaceutical companies, Kenny has excelled in drug discovery, early clinical development, and innovative deal-making. Notably, at various locations, he led R&D teams and brought numerous infectious disease therapeutics to the clinic.

Additionally, Kenny led global external innovation at a leading pharmaceutical company for infectious diseases, vaccines, and platform technologies, focusing on collaborations and transactions. He possesses a strong skill set in navigating interactions across functions such as R&D, business development, commercial strategy, IP, finance, and communications. Kenny has also provided mentorship to biotech startups globally and has evaluated investment opportunities.

​

Aaron Smith is an accomplished executive and entrepreneur with a distinguished 30+ year career in successful medical technology companies. Throughout his professional journey, he has played key roles guiding companies through rapid growth and leading to successful exits, including notable acquisitions by prominent organizations. Most recently, Aaron served as the Chief Executive Officer of a Dynamic Innovations Company for Tendon and Ligament Injuries. He joined as the sole employee in 2017, successfully leading it to a highly valued acquisition in 2024. With a background in Biomedical Engineering, Aaron boasts deep expertise in product and market strategy, commercial scale-up, fundraising, board administration, and mergers and acquisitions. Currently, he serves as a strategic advisor and/or board member for multiple medical technology companies and venture investors, showcasing his continued commitment to driving innovation and success in the industry.

Peter Stebbins is a seasoned MedTech professional with over 30 years of experience spanning operational strategy, business development, and leadership. An expert in surgical innovation and neurotechnology with an engineering and business background, Peter's expansive career includes roles at renowned medical device corporations and recent advisory positions at VC-funded startups and PE-backed firms. He combines technical acumen with insightful strategies to drive growth and innovation in healthcare.

Dushyanth Surakanti is a highly regarded senior executive whose strategic insight and leadership have significantly impacted the medical device and pharmaceutical industries. His expertise spans the entire product lifecycle, emphasizing new product conceptualization, prototyping, clinical development, manufacturing, and market introduction. Through his visionary leadership, Dushyanth has become a pivotal figure in transforming challenges into competitive advantages, solidifying his status as a champion of change within the healthcare ecosystem.

Chris Wright is an accomplished Sales & Marketing executive in the healthcare industry, with a 20+ year track record of surpassing expectations through effective communication, strategic planning, and tactical execution. Known for his focus on results and ability to thrive in fast-paced, high-growth environments, Chris brings exceptional value to any medical device organization. He has demonstrated formidable leadership in developing short-term and long-term growth strategies, excelling in process management and strategic planning. Chris stands out as a commercialization expert, with a comprehensive background in healthcare sales and marketing, ready to lead teams to new heights of success.